Total Funding
76
48
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35206
VerAvanti seeks to become the world's foremost provider of cutting-edge, single use intravascular endoscopic technologies.
- Luis Savastano: Chief Medical Officer
- Juan Vegarra: Chief Marketing OfficerPast Role: The Security Agency LLC, Managing Partner
About the Company
VerAvanti is a deep tech enterprise dedicated to bringing Scanning Fiber Endoscopy (“SFE”) to the field of medicine. SFE technology will provide 1080p video images using a single use sterile 1 mm. imaging catheter. We are finalizing the manufacturing process to mass produce the single use sterile SFE and expect to introduce a family of
groundbreaking medical devices early-2026. SFE technology is a quantum leap forward in medical imaging and will provide currently unavailable visualization capabilities.
